Mechanism of antitremorine-activity of adrenergic beta-receptor antagonists in the rat.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000605:Amino Alcohols / Q000627:therapeutic use*; D007274:Injections, Intraperitoneal; D010627:Phenethylamines / Q000627:therapeutic use*; D011433:Propranolol / Q000627:therapeutic use*; D012601:Scopolamine / Q000627:therapeutic use; D013565:Sympatholytics / Q000627:therapeutic use*; D014202:Tremor / Q000139:chemically induced / Q000188:drug therapy*; D014203:Tremorine
D000319:Adrenergic beta-Antagonists; D000605:Amino Alcohols; D010627:Phenethylamines; D013565:Sympatholytics; D011433:Propranolol; D012601:Scopolamine; D014203:Tremorine